Zealand Pharma shares surge after positive results of weight-loss drug that could contend with GLP-1s

Read Time:7 Second

Zealand Pharma said a second trial of patients on a higher dosage of its weight-loss drug showed an 8.6% drop in body weight.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

Fed commentary could give a further shot in the arm to AI names that have been market leaders, but the...

Consumers have cast their votes for the financial services companies they trust the most

One Bank of America strategist thinks the Federal Reserve’s decision to cut interest-rates by 50 basis points this week will...

Intuitive Machines is “the leading beneficiary of NASA’s lunar commercialization efforts,” says B. Riley Securities analyst Mike Crawford.

Oil futures were on track for solid weekly gains, boosted by the Federal Reserve’s large rate cut and a renewed...

Analysts sees a potential spinoff of FedEx’s freight business as a potential boost, but the stock is dropping sharply